BIO Statement on U.S.-China Comprehensive Economic Dialogue

Washington, D.C. (May 12, 2017) – The Biotechnology Innovation Organization (BIO) issued the following statement regarding initial results of the 100-Day Action Plan of the U.S.-China Comprehensive Economic Dialogue:

Convention Programming to Feature “One Health” Concept

Bio-based Technologies Address Human, Animal, Plant and Environmental Health Washington, D.C. (May 11, 2017) – At its heart, the concept of One Health is rooted in the notion that the health of humans, animals, and the environment are all interconnected. At BIO’s 2017 International Convention (June 19-22 in San Diego), programming will feature the One Health concept through stories that show how science and technology are making tomorrow’s breakthroughs possible.  

Ann Romney to Deliver Keynote at 2017 BIO International Convention

Former First Lady of Massachusetts and New York Times best-selling author will speak about the power of resilience in overcoming obstacles, advocating for families and spearheading brain health research

BIO Congratulates Dr. Scott Gottlieb on Confirmation as FDA Commissioner

Washington, DC (May 9, 2017) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the confirmation of Dr. Scott Gottlieb as Commissioner of the Food and Drug Administration (FDA):

BIO Thanks Sen. Wyden for Clean Fuel Production Tax Credit Proposal

BIO today thanked Sen. Ron Wyden (D-OR) and 21 Senate co-sponsors for proposing a technology neutral tax credit for domestic production of clean transportation fuel. Sen. Wyden’s Clean Energy for America Act proposes a set of long-term energy tax incentives that are available to all technologies and promote performance based clean energy in the United States. BIO supports Sen. Wyden’s efforts to ensure that any tax reform package Congress considers includes incentives that promote the development and production of advanced and cellulosic biofuels.

BIO Applauds Bipartisan Introduction of the PARTNER Act

Washington, DC (May 4, 2017) – Today, the Biotechnology Innovation Organization (BIO) thanks Reps. Pat Meehan (R-PA), Richard Neal (D-MA), Mike Kelly (R-PA), Ron Kind (D-WI), and John Larson (D-CT) for introducing the Partnerships to Advance Revolutionary Technology and Novel Entrepreneurial Research (PARTNER) Act.  This important legislation would support early-stage capital formation by incentivizing investment in R&D-focused small businesses.

BIO Partners with NIH and NSF for Fourth “Innovation Zone” Exhibit

SBIR-funded companies will showcase biotechnology breakthroughs at BIO 2017 International Convention 

Report Shows GM Crops Favored by World’s Farmers

Global Adoption of Biotech Crops Reaches New Peak of 457 Million Acres Washington, D.C. (May 4, 2017) – Millions of farmers around the world continue to choose genetically modified (GM) crop varieties because of their environmental and socio-economic benefits and the important role they play in addressing food security, according to a study released today.

BIO Statement on Blue Cross Blue Shield Prescription Drug Spending Report

Washington, DC (May 3, 2017) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding today’s prescription...

BIO World Congress Announces New Education Track and Plenary Session on Food Ingredients and Personal Care

The 2017 BIO World Congress on Industrial Biotechnology education program features seven diverse education tracks with speakers from around the world over three days of the conference.